DanielWillemHommesMDPhD
Gastroenterology • Los Angeles, CAProfessor, Medicine, University of California Los Angeles David Geffen SOM
Are you Dr. Hommes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plz
365 A
Los Angeles, CA 90095Phone+1 310-825-1597Fax+1 310-794-9718
Summary
- Dr. Daniel Hommes, MD is a gastroenterologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is a Professor at University of California Los Angeles David Geffen SOM.
Education & Training
University of Amsterdam Faculty of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2011 - 2019
Clinical Trials
- Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease Start of enrollment: 2010 Jun 01
- Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment Start of enrollment: 2014 Feb 01
- OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome Start of enrollment: 2017 Feb 28
Publications & Presentations
PubMed
- 142 citationsNovel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligandsMark Löwenberg, Cindy Stahn, Daniel W. Hommes, Frank Buttgereit
Steroids. 2008-10-01 - 27 citationsNeutralizing antibodies against adeno‐associated viruses in inflammatory bowel disease patients: Implications for gene therapySander van der Marel, Elisabeth M. Comijn, Hein W. Verspaget, Sander J. H. van Deventer, Gijs R. van den Brink
Inflammatory Bowel Diseases. 2011-12-01 - 277 citationsMolecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonistsCindy Stahn, Mark Löwenberg, Daniel W. Hommes, Frank Buttgereit
Molecular and Cellular Endocrinology. 2007-09-15
Press Mentions
InterVenn Biosciences to Present Clinical Data on Circulating Serum Glycoproteins for Unprecedented Pre-Cancer Detection as “Poster of Distinction” at Digestive Disease Week 2023April 19th, 2023- DEARhealth Becomes One of the World’s First Companies to Obtain CE-Marking According to New European Union Medical Device Regulation (MDR)June 10th, 2021
- DEARhealth Recruits Senior Executives to Accelerate GrowthMarch 30th, 2021
Other Languages
- Dutch, Spanish
